Browse News
Filter News
Found 561,875 articles
-
With the positive results from this trial, as well as an earlier Phase III trial, Myovant Sciences plans to seek regulatory approval later this year.
-
A new technique, DNA microscopy, is allowing scientists to visualize DNA in a way not previously possible. And there isn’t even an actual microscope involved.
-
In the trial, 396 patients with moderate-to-severe psychotic symptoms related to adult schizophrenia received either Nuplazid or placebo added to their current antipsychotic treatment. The patients receiving Nuplazid showed a consistent trend in symptom improvement but did not hit statistical sig...
-
If you are feeling undervalued at work, it’s productive to think about how you’ve demonstrated your value internally. Here are four ways to demonstrate your worth in the workplace!
-
At 96 weeks, 60% of the heavily pretreated HIV patients dosed with ViiV's experimental treatment achieved virologic suppression.
-
Sanofi will be responsible for leading the clinical program and funding all studies needed to support the over-the-counter switch in the United States and will also be responsible for the regulatory submissions.
-
"Our ultimate goal is to provide a solution to an organ shortage that causes an average of 20 people per day in the U.S. alone to die waiting for an organ transplant," quoted Rich Boling, the vice-president of corporate advancement at Techshot.
-
Today, Civica Rx announced a five-year deal with London, UK-based Hikma Pharmaceuticals to manufacture and supply Civica’s members with 14 sterile injectable drugs as a private label distributor.
-
Research recently published by researchers from The Scripps Research Institute in the Proceedings of the National Academy of Sciences found that exosomes play an integral role in the development of neurons and neural circuits. In addition, they are able to fix brain cells damaged by developmental...
-
Researchers with the Weizmann Institute of Science worked with mice with an ALS-like disease. They found that the course of the disease slowed after the mice received specific strains of gut microbes or substances that were secreted by the microbes. The results suggest that the microbiome may pla...
-
Luna Design and Innovation selected as a Channel Partner for Blue Origin
7/23/2019
Luna Design and Innovation Inc., a Toronto-based biotechnology company, announced that it has been selected as an Official Channel Partner for Blue Origin’s New Shepard reusable suborbital rocket system.
-
Informative Guide to Effective Sample Management
7/23/2019
Ziath has published a comprehensive guide entitled 'Tips, tricks and solutions for effective sample management' in an easy-to-use eBook format.
-
pMD Announces Free Secure Patient Communication
7/23/2019
pMD, the innovation leader in health care technology, today announced a free HIPAA-compliant communication platform to better connect providers with patients
-
HMS Engages Amendola to Drive Expansion Through PR and Media Relations
7/23/2019
Amendola Communications, a nationally recognized, award-winning healthcare and health IT public relations and marketing agency, has announced it has been selected as the public relations and media relations partner for HMS, a leading healthcare technology company that helps healthcare organizations reduce costs and improve health outcomes.
-
PolyActiva Completes Recruitment in Key Phase I Glaucoma Implant Safety Study. Six-month Treatment Period Demonstrated.
7/23/2019
PolyActiva Pty Ltd, a clinical-stage biotechnology company and leader in ocular drug delivery, has completed patient enrolment for its Phase I clinical trial to study safety and tolerability of its biodegradable, slow-release ocular implant for the treatment of glaucoma.
-
Southern Smash to Join Forces and Merge with The Alliance for Eating Disorders Awareness
7/23/2019
Southern Smash, a nonprofit that organizes events that challenge individuals to redefine their worth and beauty by letting go and SMASH those perfect numbers and thoughts that weigh them down, will become a program under the national nonprofit The Alliance for Eating Disorders Awareness.
-
Camurus Announces Positive Outcome of U.S. Court Proceeding About Final Approval of Brixadi™
7/23/2019
Camurus AB (NASDAQ STO: CAMX) today announces that the United States District Court for the District of Columbia grants Braeburn's motion for summary judgement, vacating the U.S. Food and Drug Administration's (FDA) decision to block final market approval of Brixadi™ Monthly.
-
Magellan Health Announces Second Quarter 2019 Earnings Conference Call
7/23/2019
Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will report its earnings for the second quarter ended on June 30, 2019 at approximately 6:30 a.m. Eastern on Tuesday, July 30, 2019.
-
Vizor Introduces Next Generation Zinc Oxide Technology That Enable Higher SPF Sunscreens
7/23/2019
Vizor, LLC today announced it has launched two new next-generation inorganic sunscreen ingredients based on patent-pending surface modification technology that can deliver substantially higher SPF values with less material and better performance than conventional zinc oxide ingredients
-
GetInsured Announces First to Market Phase 3 Enhanced Direct Enrollment (EDE) CMS Platform
7/23/2019
GetInsured, a market leader in individual health insurance e-commerce, today announced it is the first company to pass the official Center for Medicare & Medicaid Services (CMS) audit and has been approved to offer Phase 3 Enhanced Direct Enrollment (EDE) technology.